{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:17:05Z","timestamp":1788538625380,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023673","name":"Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jmgm.2026.109515","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:38:14Z","timestamp":1783985894000},"page":"109515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Machine learning and docking-based insights into descriptor, activity, and chirality cliffs of SYK inhibitors"],"prefix":"10.1016","volume":"148","author":[{"given":"Vijay H.","family":"Masand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithilesh M.","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami A.","family":"Al-Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Y.A.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumer D.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E.A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jmgm.2026.109515_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"M\u00f3csai","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jmgm.2026.109515_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107168","article-title":"Recent advance of spleen tyrosine kinase in diseases and drugs","volume":"90","author":"Shao","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"13\u201314","key":"10.1016\/j.jmgm.2026.109515_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.drudis.2010.05.001","article-title":"Spleen tyrosine kinases: biology, therapeutic targets and drugs","volume":"15","author":"Riccaboni","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2026.109515_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/270302","article-title":"Functional roles of syk in macrophage-mediated inflammatory responses","volume":"2014","author":"Yi","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109515_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1693-z","article-title":"Dectin-1\/Syk signaling triggers neuroinflammation after ischemic stroke in mice","volume":"17","author":"Ye","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.jmgm.2026.109515_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12130","article-title":"The spleen tyrosine kinase (SYK): a crucial therapeutic target for diverse liver diseases","volume":"8","author":"Zhao","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.jmgm.2026.109515_bib7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.29881","article-title":"Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis","volume":"68","author":"Qu","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jmgm.2026.109515_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01403-w","article-title":"SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer","volume":"8","author":"Zhou","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jmgm.2026.109515_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cellsig.2018.03.012","article-title":"Melatonin therapy for diabetic cardiomyopathy: a mechanism involving syk-mitochondrial complex I-SERCA pathway","volume":"47","author":"Zhou","year":"2018","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109515_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3748\/wjg.v26.i10.1005","article-title":"Role of spleen tyrosine kinase in liver diseases","volume":"26","author":"Kurniawan","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"23","key":"10.1016\/j.jmgm.2026.109515_bib11","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1038\/s41388-019-0734-5","article-title":"Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis","volume":"38","author":"Torres-Hernandez","year":"2019","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074550","article-title":"Spleen tyrosine kinase (Syk) regulates systemic lupus erythematosus (SLE) T cell signaling","volume":"8","author":"Grammatikos","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jmgm.2026.109515_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/ar3198","article-title":"Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases","volume":"12","author":"Pamuk","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.tips.2014.05.007","article-title":"Getting syk: spleen tyrosine kinase as a therapeutic target","volume":"35","author":"Geahlen","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"14","key":"10.1016\/j.jmgm.2026.109515_bib15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","article-title":"An oral spleen tyrosine kinase (Syk) inhibitor for Rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.jmgm.2026.109515_bib16","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1016\/j.bmcl.2011.07.082","article-title":"Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor","volume":"21","author":"Liddle","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"12","key":"10.1016\/j.jmgm.2026.109515_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123114","article-title":"Discovery of a natural syk inhibitor from Chinese medicine through a docking-based virtual screening and biological assay Study","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102247","article-title":"Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors","volume":"298","author":"Arter","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109515_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/oxfordjournals.jbchem.a002970","article-title":"Structure and function of syk protein-tyrosine kinase","volume":"130","author":"Sada","year":"2001","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109515_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tibs.2010.09.006","article-title":"Protein kinases: evolution of dynamic regulatory proteins","volume":"36","author":"Taylor","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"19","key":"10.1016\/j.jmgm.2026.109515_bib21","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1111\/febs.13831","article-title":"Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs","volume":"283","author":"Lee","year":"2016","journal-title":"FEBS J."},{"issue":"45","key":"10.1016\/j.jmgm.2026.109515_bib22","doi-asserted-by":"crossref","first-page":"35442","DOI":"10.1074\/jbc.M004549200","article-title":"Phosphorylation of syk activation loop tyrosines is essential for syk function","volume":"275","author":"Zhang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109515_bib23","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.str.2024.09.024","article-title":"The mechanism of allosteric activation of SYK kinase derived from multiple phospho-ITAM-bound structures","volume":"32","author":"Bradshaw","year":"2024","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.jmgm.2026.109515_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jmb.2012.11.007","article-title":"M\u00fcller-Pompalla D and others. Structural and biophysical characterization of the syk activation switch","volume":"425","author":"Gr\u00e4dler","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2026.109515_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00078","article-title":"Targeting syk in autoimmune rheumatic diseases","volume":"7","author":"Deng","year":"2016","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jmgm.2026.109515_bib26","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/art.27452","article-title":"Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus\u2010prone mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jmgm.2026.109515_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3899\/jrheum.120923","article-title":"Effects of fostamatinib (R788), an oral spleen tyrosine Kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial","volume":"40","author":"Weinblatt","year":"2013","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109515_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/d41573-019-00014-x","article-title":"2018 FDA drug approvals","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40265-021-01524-y","article-title":"Fostamatinib: a review in chronic immune thrombocytopenia","volume":"81","author":"Paik","year":"2021","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib30","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/j.clml.2018.05.022","article-title":"An open-label, phase II trial of entospletinib (GS-9973), a selective spleen tyrosine Kinase inhibitor, in diffuse large B-cell lymphoma","volume":"18","author":"Burke","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.jmgm.2026.109515_bib31","first-page":"1","article-title":"Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase\/janus kinase inhibitor, in relapsed\/refractory peripheral T-cell lymphoma","author":"Horwitz","year":"2025","journal-title":"Leuk. Lymphoma"},{"issue":"7","key":"10.1016\/j.jmgm.2026.109515_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.25125","article-title":"Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo\u2010controlled trials","volume":"93","author":"Bussel","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109515_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12185-025-03924-2","article-title":"Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia","volume":"121","author":"Kuwana","year":"2025","journal-title":"Int. J. Hematol."},{"issue":"12","key":"10.1016\/j.jmgm.2026.109515_bib34","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1039\/D4MD00522H","article-title":"Recent advances from computer-aided drug design to artificial intelligence drug design","volume":"15","author":"Wang","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109515_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.909111","article-title":"3D-QSAR-Based pharmacophore modeling, virtual screening, and molecular dynamics simulations for the identification of spleen tyrosine kinase inhibitors","volume":"12","author":"Kumar","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jmgm.2026.109515_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2022.1074797","article-title":"Enhanced utility of AI\/ML methods during lead optimization by inclusion of 3D ligand information","volume":"2","author":"Bleicher","year":"2022","journal-title":"Frontiers in Drug Discovery"},{"key":"10.1016\/j.jmgm.2026.109515_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molstruc.2019.04.009","article-title":"In silico structural anatomization of spleen tyrosine kinase inhibitors: pharmacophore modeling, 3D QSAR analysis and molecular docking studies","volume":"1189","author":"Ganjoo","year":"2019","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109515_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11224-018-1189-y","article-title":"A study of pyrazolo-benzimidazole derivatives as spleen tyrosine kinase inhibitors: an in-silico approach","volume":"30","author":"Dubey","year":"2018","journal-title":"Struct. Chem."},{"issue":"14","key":"10.1016\/j.jmgm.2026.109515_bib39","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1080\/07391102.2016.1240108","article-title":"Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3)","volume":"35","author":"Kaur","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109515_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4018\/IJQSPR.20200701.oa1","article-title":"Principles of QSAR modeling","volume":"5","author":"Gramatica","year":"2020","journal-title":"International Journal of Quantitative Structure-Property Relationships"},{"issue":"3","key":"10.1016\/j.jmgm.2026.109515_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/cem.70014","article-title":"Origin of the OECD principles for QSAR validation and their role in changing the QSAR paradigm worldwide: an historical overview","volume":"39","author":"Gramatica","year":"2025","journal-title":"J. Chemometr."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib42","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1021\/ci200179y","article-title":"Lessons learned from molecular scaffold analysis","volume":"51","author":"Hu","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib43","first-page":"1341","article-title":"A chemoinformatic analysis of atoms, scaffolds and functional groups in natural products","volume":"8","author":"Hanna","year":"2023","journal-title":"Phys. Sci. Rev."},{"issue":"10","key":"10.1016\/j.jmgm.2026.109515_bib44","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41596-021-00597-z","article-title":"A practical guide to large-scale docking","volume":"16","author":"Bender","year":"2021","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109515_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39939-z","article-title":"Merits and pitfalls of conventional and covalent docking in identifying new hydroxyl aryl aldehyde like compounds as human IRE1 inhibitors","volume":"9","author":"Carlesso","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109515_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-025-00963-z","article-title":"Fifteen years of ChEMBL and its role in cheminformatics and drug discovery","volume":"17","author":"Zdrazil","year":"2025","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2026.109515_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-0716-0150-1_5","article-title":"Importance of data curation in QSAR studies especially while modeling large-size datasets. Ecotoxicological QSARs","author":"Ambure","year":"2020","journal-title":"Methods in Pharmacology and Toxicology"},{"issue":"11","key":"10.1016\/j.jmgm.2026.109515_bib48","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1039\/D0CS00098A","article-title":"QSAR without borders","volume":"49","author":"Muratov","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.jmgm.2026.109515_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/1062936X.2020.1784271","article-title":"Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling","volume":"31","author":"Masand","year":"2020","journal-title":"SAR QSAR Environ. Res."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109515_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an Open-Source Program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.jmgm.2026.109515_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2026.109515_bib52","first-page":"32","article-title":"PyDescriptorC\u2217: a descriptor calculation tool for decoding chirality cliffs and revealing hidden patterns in drug discovery","volume":"21","author":"Masand","year":"2025","journal-title":"RHAZES: Green and Applied Chemistry"},{"key":"10.1016\/j.jmgm.2026.109515_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.chemolab.2017.08.003","article-title":"A new PyMOL plugin for calculating thousands of easily understandable molecular descriptors","volume":"169","author":"Masand","year":"2017","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2026.109515_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2025.100872","article-title":"Identification of pharmacophore synergism for optimization of estrogen receptor beta binders for hormone dependent forms of breast cancer","volume":"10","author":"Hussien","year":"2025","journal-title":"Chem. Phys. Impact"},{"issue":"23","key":"10.1016\/j.jmgm.2026.109515_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314527","article-title":"Pharmacophore synergism in diverse scaffold clinches in Aurora kinase B","volume":"23","author":"Masand","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109515_bib56","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00044-014-1193-8","article-title":"Effect of information leakage and method of splitting (rational and random) on external predictive ability and behavior of different statistical parameters of QSAR model","volume":"24","author":"Masand","year":"2014","journal-title":"Med. Chem. Res."},{"issue":"7","key":"10.1016\/j.jmgm.2026.109515_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071834","article-title":"QSAR and pharmacophore modeling of nitrogen heterocycles as potent human N-Myristoyltransferase (Hs-NMT) inhibitors","volume":"26","author":"Zaki","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jmgm.2026.109515_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cem.1180060506","article-title":"Genetic algorithms as a strategy for feature selection","volume":"6","author":"Leardi","year":"2005","journal-title":"J. Chemometr."},{"issue":"24","key":"10.1016\/j.jmgm.2026.109515_bib59","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jcc.23361","article-title":"QSARINS: a new software for the development, analysis, and validation of QSAR MLR models","volume":"34","author":"Gramatica","year":"2013","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.jmgm.2026.109515_bib60","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109515_bib61","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1039\/D2CS00948J","article-title":"Surely you are joking, Mr Docking","volume":"52","author":"Gentile","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.jmgm.2026.109515_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad047","article-title":"Dockey: a modern integrated tool for large-scale molecular docking and virtual screening","volume":"24","author":"Du","year":"2023","journal-title":"Briefings Bioinf."},{"issue":"11","key":"10.1016\/j.jmgm.2026.109515_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200072","article-title":"The relevance of goodness\u2010of\u2010fit, robustness and prediction validation categories of OECD\u2010QSAR principles with respect to sample size and model type","volume":"41","author":"Kir\u00e1ly","year":"2022","journal-title":"Mol. Inf."},{"issue":"1\u20132","key":"10.1016\/j.jmgm.2026.109515_bib64","article-title":"On the misleading use of for QSAR model comparison","volume":"38","author":"Consonni","year":"2018","journal-title":"Mol. Inf."},{"issue":"4","key":"10.1016\/j.jmgm.2026.109515_bib65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/minf.201400030","article-title":"External evaluation of QSAR models, in addition to Cross\u2010Validation: verification of predictive capability on totally new chemicals","volume":"33","author":"Gramatica","year":"2014","journal-title":"Mol. Inf."},{"issue":"3","key":"10.1016\/j.jmgm.2026.109515_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030303","article-title":"Exploring the prominent and concealed inhibitory features for cytoplasmic isoforms of Hsp 90 using QSAR analysis","volume":"15","author":"Zaki","year":"2022","journal-title":"Pharmaceuticals"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632600241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632600241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:37:45Z","timestamp":1788536265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332632600241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":66,"alternative-id":["S109332632600241X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109515","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning and docking-based insights into descriptor, activity, and chirality cliffs of SYK inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109515"}}